The Challenges of Drug Delivery for Retinal Diseases
Global experts who manage patients with retinal disorders comment on current treatment barriers and highlight newer therapies and delivery systems coming to market.
EP. 1: Common Types of Retinal Disorders Explored
A panel of global experts who treat patients with retinal diseases suggest causes of age-related macular degeneration, diabetic macular edema, and inherited retinal disease.
EP. 2: Evaluating Patients for a Retinal Disorder
Types of tests and criteria that can be used to diagnose conditions such as age-related macular degeneration, diabetic macular edema, and inherited retinal disease.
EP. 3: Age-Related Macular Degeneration: Treatment Overview
An overview of the current treatment landscape for age-related macular degeneration and factors that impact treatment selection.
EP. 4: Diabetic Macular Edema: Treatment Overview
A discussion regarding the roles of various treatments available for diabetic macular edema and considerations for selecting and sequencing therapy.
EP. 5: Inherited Retinal Disease: Treatment Overview
Dr Mariya Moosajee highlights therapies approved as well as under study to improve treatment for patients with inherited retinal disease.
EP. 6: Anti-VEGF Therapy for Retinal Disease
Drawbacks and challenges associated with the administration of anti-VEGF injections currently available to treat retinal diseases.
EP. 7: Drug Delivery Challenges in Retinal Disease
Challenges associated with delivering therapies currently available to treat retinal disorders and methods being explored to improve drug delivery to patients.
EP. 8: Addressing Drug Delivery Gaps in Retinal Disease
Following a discussion regarding drug delivery challenges in retinal disease, a panel of global experts suggest what types of technological requirements and improvements they would like to see occur in the field.
EP. 10: Recent Treatment Advances in Retinal Disease
Ophthalmologists highlight recent treatment advances in diabetic macular edema and wet age-related macular degeneration.
EP. 11: Therapies in the Pipeline for Retinal Disorders
A discussion highlighting new agents under investigation for retinal disorders and implications for future use based on data revealed in more recent clinical trials.
EP. 13: Sustained-Release Drug Delivery for Retinal Disorders
Considerations for treating retinal disorders with sustained-release drug delivery implants in an effort to address current treatment challenges in the field.
EP. 14: Future Gene Therapy for Inherited Retinal Disease
Dr Mariya Moosajee comments on the next generation of gene therapy for inherited retinal disease and highlights various systems under investigation.
EP. 15: Managing Retinal Disorders: Lessons Learned From COVID-19
The impact of the COVID-19 pandemic on the management of patients with retinal disorders and considerations for how new practices may be adopted into future practice.
EP. 16: Optimizing Care For Patients With Retinal Disorders
Key takeaways from a discussion on the management of age-related macular degeneration, diabetic macular edema, and inherited retinal disease and insight regarding what to look forward to as the field advances.
